{"id":137032,"date":"2026-07-02T10:19:01","date_gmt":"2026-07-02T04:49:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=137032"},"modified":"2026-07-02T10:19:03","modified_gmt":"2026-07-02T04:49:03","slug":"nath-bio-genes-india-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/","title":{"rendered":"Nath Bio-Genes (India) Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Nath Bio-Genes (India) CMP Rs 168. 52W High Rs 239 | Low Rs 126. Mcap Rs 310 Cr. 12M Target Rs 225. PE: 7.45.<\/em><\/p>\n<p>The <a href=\"https:\/\/univest.in\/user\/stocks\/nathbiogen\/nath-bio-share-price-today\">Nath Bio-Genes (India)<\/a> share price target stands at Rs 225 for 2026, implying approximately 34% upside from the current market price of Rs 168. The stock trades at a price-to-earnings ratio of 7.45x, reflecting attractive value versus sector peers, with a market capitalisation of Rs 310 Cr. Investors tracking the seeds &amp; agri segment are closely watching <a href=\"https:\/\/univest.in\/stocks\/nathbiogen\/nath-bio-share-price-today\">Nath Bio-Genes (India)<\/a> as an emerging opportunity given its 52-week range of Rs 126 to Rs 239. This analysis covers the bull case, bear case, and key catalysts that will define the Nath Bio-Genes (India) share price target trajectory through 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=nath-bio-genes-india-target\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Nath_Bio-Genes_India_Company_Overview_and_Key_Metrics\" title=\"Nath Bio-Genes (India) Company Overview and Key Metrics\">Nath Bio-Genes (India) Company Overview and Key Metrics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Why_Is_the_Nath_Bio-Genes_India_share_price_target_Set_at_Rs_225_for_2026\" title=\"Why Is the Nath Bio-Genes (India) share price target Set at Rs 225 for 2026\">Why Is the Nath Bio-Genes (India) share price target Set at Rs 225 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Strong_Domestic_Consumption_and_Growing_Middle_Class\" title=\"Strong Domestic Consumption and Growing Middle Class\">Strong Domestic Consumption and Growing Middle Class<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Favourable_Policy_Environment_and_Make_in_India_Push\" title=\"Favourable Policy Environment and Make in India Push\">Favourable Policy Environment and Make in India Push<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Union_Budget_2026_and_Policy_Tailwinds\" title=\"Union Budget 2026 and Policy Tailwinds\">Union Budget 2026 and Policy Tailwinds<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Nath_Bio-Genes_India_Share_Price_Target_Short_Term_12_Month_and_Long_Term\" title=\"Nath Bio-Genes (India) Share Price Target Short Term, 12 Month and Long Term\">Nath Bio-Genes (India) Share Price Target Short Term, 12 Month and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Short_Term_Nath_Bio-Genes_India_Share_Price_Target_3_to_6_Months\" title=\"Short Term Nath Bio-Genes (India) Share Price Target: 3 to 6 Months\">Short Term Nath Bio-Genes (India) Share Price Target: 3 to 6 Months<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#12_Month_Nath_Bio-Genes_India_Share_Price_Target_2026\" title=\"12 Month Nath Bio-Genes (India) Share Price Target 2026\">12 Month Nath Bio-Genes (India) Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Long_Term_Nath_Bio-Genes_India_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Nath Bio-Genes (India) Share Price Target: FY27 to FY28\">Long Term Nath Bio-Genes (India) Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Bull_Case_and_Bear_Case_for_Nath_Bio-Genes_India_Share_Price_Target\" title=\"Bull Case and Bear Case for Nath Bio-Genes (India) Share Price Target\">Bull Case and Bear Case for Nath Bio-Genes (India) Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Bull_Case_Rs_260\" title=\"Bull Case: Rs 260\">Bull Case: Rs 260<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Bear_Case_Rs_180\" title=\"Bear Case: Rs 180\">Bear Case: Rs 180<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Key_Risks_to_the_Nath_Bio-Genes_India_Share_Price_Target_2026\" title=\"Key Risks to the Nath Bio-Genes (India) Share Price Target 2026\">Key Risks to the Nath Bio-Genes (India) Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Macro_Headwind_from_Global_Slowdown_and_US_Tariff_Policy\" title=\"Macro Headwind from Global Slowdown and US Tariff Policy\">Macro Headwind from Global Slowdown and US Tariff Policy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Valuation_Risk_and_Earnings_Miss_Scenario\" title=\"Valuation Risk and Earnings Miss Scenario\">Valuation Risk and Earnings Miss Scenario<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Competitive_Pressure_in_the_Seeds_Agri_Segment\" title=\"Competitive Pressure in the Seeds &amp; Agri Segment\">Competitive Pressure in the Seeds &amp; Agri Segment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#FII_Selling_and_Broader_Market_Volatility\" title=\"FII Selling and Broader Market Volatility\">FII Selling and Broader Market Volatility<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#How_to_Invest_in_Nath_Bio-Genes_India_Stock\" title=\"How to Invest in Nath Bio-Genes (India) Stock\">How to Invest in Nath Bio-Genes (India) Stock<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#FAQs_on_Nath_Bio-Genes_India_Share_Price_Target_2026\" title=\"FAQs on Nath Bio-Genes (India) Share Price Target 2026\">FAQs on Nath Bio-Genes (India) Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#What_is_the_Nath_Bio-Genes_India_share_price_target_for_2026\" title=\"What is the Nath Bio-Genes (India) share price target for 2026?\">What is the Nath Bio-Genes (India) share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Is_Nath_Bio-Genes_India_a_good_stock_to_buy_right_now\" title=\"Is Nath Bio-Genes (India) a good stock to buy right now?\">Is Nath Bio-Genes (India) a good stock to buy right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#What_is_Nath_Bio-Genes_Indias_52-week_high_and_low\" title=\"What is Nath Bio-Genes (India)&#8217;s 52-week high and low?\">What is Nath Bio-Genes (India)&#8217;s 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#What_is_the_market_cap_of_Nath_Bio-Genes_India\" title=\"What is the market cap of Nath Bio-Genes (India)?\">What is the market cap of Nath Bio-Genes (India)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#What_are_the_key_risks_to_the_Nath_Bio-Genes_India_share_price_target\" title=\"What are the key risks to the Nath Bio-Genes (India) share price target?\">What are the key risks to the Nath Bio-Genes (India) share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#What_is_the_bull_case_target_for_Nath_Bio-Genes_India_in_2026\" title=\"What is the bull case target for Nath Bio-Genes (India) in 2026?\">What is the bull case target for Nath Bio-Genes (India) in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#Where_can_I_track_Nath_Bio-Genes_India_share_price_live\" title=\"Where can I track Nath Bio-Genes (India) share price live?\">Where can I track Nath Bio-Genes (India) share price live?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-share-price-target-2026\/#How_do_I_invest_in_Nath_Bio-Genes_India_stock\" title=\"How do I invest in Nath Bio-Genes (India) stock?\">How do I invest in Nath Bio-Genes (India) stock?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Nath_Bio-Genes_India_Company_Overview_and_Key_Metrics\"><\/span><strong>Nath Bio-Genes (India) Company Overview and Key Metrics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\" border=\"1\" cellspacing=\"0\" cellpadding=\"8\">\n<thead>\n<tr style=\"background: #f2f2f2;\">\n<th>Nath Bio-Genes (India)<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>NSE Symbol<\/strong><\/td>\n<td>NATHBIOGEN<\/td>\n<\/tr>\n<tr>\n<td><strong>Sector<\/strong><\/td>\n<td>Seeds &amp; Agri<\/td>\n<\/tr>\n<tr>\n<td><strong>CMP (Rs)<\/strong><\/td>\n<td>168<\/td>\n<\/tr>\n<tr>\n<td><strong>52W High (Rs)<\/strong><\/td>\n<td>239<\/td>\n<\/tr>\n<tr>\n<td><strong>52W Low (Rs)<\/strong><\/td>\n<td>126<\/td>\n<\/tr>\n<tr>\n<td><strong>Market Cap (Rs Cr)<\/strong><\/td>\n<td>310 Cr<\/td>\n<\/tr>\n<tr>\n<td><strong>P\/E Ratio<\/strong><\/td>\n<td>7.45<\/td>\n<\/tr>\n<tr>\n<td><strong>12M Target (Rs)<\/strong><\/td>\n<td>225<\/td>\n<\/tr>\n<tr>\n<td><strong>Bull Case (Rs)<\/strong><\/td>\n<td>260<\/td>\n<\/tr>\n<tr>\n<td><strong>Bear Case (Rs)<\/strong><\/td>\n<td>180<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Nath Bio-Genes (India) is a seeds &amp; agri company listed on the National Stock Exchange (NSE: NATHBIOGEN). With a market capitalisation of Rs 310 Cr, the company occupies a defined position in the Indian seeds &amp; agri landscape. The stock has traded in a wide range over the past 12 months, touching a high of Rs 239 and a low of Rs 126, before arriving at its current level of Rs 168. Uniresearch analysts project a 12-month Nath Bio-Genes (India) share price target of Rs 225, with a bull case of Rs 260 and a bear case of Rs 180.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Nath_Bio-Genes_India_share_price_target_Set_at_Rs_225_for_2026\"><\/span><strong>Why Is the Nath Bio-Genes (India) share price target Set at Rs 225 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Nath Bio-Genes (India) share price target of Rs 225 is anchored in expectations of FY27 earnings delivery. At a P\/E of 7.45x on trailing earnings, the stock is attractively valued. Consistent revenue growth and margin improvement in coming quarters can re-rate the stock towards the Rs 225 target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Strong_Domestic_Consumption_and_Growing_Middle_Class\"><\/span><strong>Strong Domestic Consumption and Growing Middle Class<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s consumption story remains intact with GDP growth projected at 6.5-7% in FY27. A rising middle class with increasing discretionary spending is expanding the addressable market for companies across most sectors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Favourable_Policy_Environment_and_Make_in_India_Push\"><\/span><strong>Favourable Policy Environment and Make in India Push<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Government initiatives promoting domestic manufacturing through PLI schemes, import substitution, and ease of doing business reforms are structurally improving the operating environment for Indian companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Reserve Bank of India has shifted to an accommodative monetary policy stance, with rate cuts reducing borrowing costs across the economy. For Nath Bio-Genes (India), lower interest rates translate to reduced finance costs and potentially higher consumer demand in its end markets, creating a favourable backdrop for the Nath Bio-Genes (India) share price target to materialise by year-end.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026_and_Policy_Tailwinds\"><\/span><strong>Union Budget 2026 and Policy Tailwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Union Budget 2026-27 has maintained strong capex allocation of Rs 11 lakh crore for infrastructure, directly benefiting sectors including seeds &amp; agri. Tax rationalisation and sector-specific policy support create a constructive policy environment that supports the Nath Bio-Genes (India) share price target thesis through improved demand visibility.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nath_Bio-Genes_India_Share_Price_Target_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Nath Bio-Genes (India) Share Price Target Short Term, 12 Month and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Nath_Bio-Genes_India_Share_Price_Target_3_to_6_Months\"><\/span><strong>Short Term Nath Bio-Genes (India) Share Price Target: 3 to 6 Months<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the near term, the Nath Bio-Genes (India) share price target for the next 3 to 6 months is pegged at Rs 180, contingent on Q1 FY27 earnings meeting expectations and sustained buying interest in the seeds &amp; agri segment. Technically, the stock needs to hold the Rs 132-139 zone for this short-term target to remain valid.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12_Month_Nath_Bio-Genes_India_Share_Price_Target_2026\"><\/span><strong>12 Month Nath Bio-Genes (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Our 12-month Nath Bio-Genes (India) share price target is Rs 225. This target is based on the Uniresearch fundamental estimate, which factors in FY27 revenue growth, margin normalisation, and sector re-rating potential. The Rs 225 level represents approximately 34% upside from the current price of Rs 168.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Nath_Bio-Genes_India_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Nath Bio-Genes (India) Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Over a 2 to 3 year horizon, the long-term Nath Bio-Genes (India) share price target is estimated between Rs 259 and Rs 304, assuming continued compounding in earnings, potential capacity expansions, and improved market positioning. Investors with a multi-year holding perspective may find the current CMP of Rs 168 an attractive accumulation level.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_Nath_Bio-Genes_India_Share_Price_Target\"><\/span><strong>Bull Case and Bear Case for Nath Bio-Genes (India) Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Rs_260\"><\/span><strong>Bull Case: Rs 260<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the bull case scenario, Nath Bio-Genes (India) delivers above-estimate earnings growth driven by strong demand, margin expansion, and new business wins. If these catalysts materialise simultaneously, the Nath Bio-Genes (India) share price target could reach Rs 260, implying approximately 55% upside from the current market price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Rs_180\"><\/span><strong>Bear Case: Rs 180<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case of Rs 180 assumes earnings disappointment, sector-level de-rating, or broader market selloff driven by FII outflows. In this scenario, Nath Bio-Genes (India) could re-test support levels closer to its 52-week low of Rs 126, representing a downside risk investors should monitor.<\/p>\n<table style=\"width: 100%; border-collapse: collapse;\" border=\"1\" cellspacing=\"0\" cellpadding=\"8\">\n<thead>\n<tr style=\"background: #f2f2f2;\">\n<th>Scenario<\/th>\n<th>Target Price (Rs)<\/th>\n<th>Upside\/Downside from CMP<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Bull Case<\/td>\n<td>260<\/td>\n<td>55%<\/td>\n<td>Strong earnings growth, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>225<\/td>\n<td>34%<\/td>\n<td>Steady earnings, margin improvement<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>180<\/td>\n<td>7%<\/td>\n<td>Earnings miss, macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Nath_Bio-Genes_India_Share_Price_Target_2026\"><\/span><strong>Key Risks to the Nath Bio-Genes (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Macro_Headwind_from_Global_Slowdown_and_US_Tariff_Policy\"><\/span><strong>Macro Headwind from Global Slowdown and US Tariff Policy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A sharper-than-expected global slowdown or escalation in US-China trade tensions could dampen demand across sectors. Nath Bio-Genes (India) faces indirect risk if its customers or supply chain partners are impacted by slower global growth, as this could translate to lower order volumes or pricing pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Risk_and_Earnings_Miss_Scenario\"><\/span><strong>Valuation Risk and Earnings Miss Scenario<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>If Nath Bio-Genes (India) reports quarterly earnings below analyst estimates or provides weak forward guidance, the stock could see significant de-rating. Elevated valuations in some segments leave limited margin for error, making execution risk a critical near-term concern.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Pressure_in_the_Seeds_Agri_Segment\"><\/span><strong>Competitive Pressure in the Seeds &amp; Agri Segment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The seeds &amp; agri space in India is increasingly competitive with both domestic players and global companies vying for market share. Price competition, product commoditisation, or loss of key client contracts could pressure Nath Bio-Genes (India)&#8217;s revenue trajectory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Selling_and_Broader_Market_Volatility\"><\/span><strong>FII Selling and Broader Market Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Foreign Institutional Investor selling in Indian equities has historically led to broad-based price corrections even in fundamentally sound companies. Nath Bio-Genes (India)&#8217;s share price could face near-term pressure if FII sentiment turns risk-off due to global monetary policy changes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Nath_Bio-Genes_India_Stock\"><\/span><strong>How to Invest in Nath Bio-Genes (India) Stock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Step 1: Research and Fundamental Analysis.<\/strong> Before investing, thoroughly review Nath Bio-Genes (India)&#8217;s quarterly results, annual report, and management commentary. Focus on revenue growth trajectory, operating margin trends, and debt levels to assess whether the Nath Bio-Genes (India) share price target of Rs 225 is achievable.<\/p>\n<p><strong>Step 2: Use Stock Screeners for Live Data.<\/strong><\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Check Nath Bio-Genes (India) Live Data on Univest Screener<\/strong><\/a><\/p>\n<p>Monitor key metrics including P\/E, return on equity, and promoter holding changes. These ratios can confirm or challenge the Nath Bio-Genes (India) share price target thesis in real time.<\/p>\n<p><strong>Step 3: Define Your Entry Zone.<\/strong> The current CMP of Rs 168 is within the identified accumulation zone based on the 52-week low of Rs 126 and the Uniresearch target of Rs 225. Consider entering in tranches to average your cost over market fluctuations.<\/p>\n<p><strong>Step 4: Set Stop Loss and Risk Management Levels.<\/strong> Always define a stop-loss level before investing. A prudent stop-loss for Nath Bio-Genes (India) based on the current technical setup would be in the Rs 147 to Rs 154 range. Never risk more than 2-5% of your portfolio in any single position.<\/p>\n<p><strong>Step 5: Open a Zero-Brokerage Demat Account.<\/strong> To invest in Nath Bio-Genes (India) at zero brokerage, open your demat account with Univest, which combines SEBI-registered research with integrated trading. This allows you to act on the Nath Bio-Genes (India) share price target analysis without incurring unnecessary transaction costs.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Nath Bio-Genes (India) live price and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Nath Bio-Genes (India) share price target for 2026 is Rs 225, with a bull case of Rs 260 and a bear case of Rs 180, based on Uniresearch estimates as of 29 June 2026. At a CMP of Rs 168 with a 52-week range of Rs 126 to Rs 239, Nath Bio-Genes (India) presents a risk-reward opportunity that warrants monitoring. Investors should review Q1 FY27 results, track management commentary on guidance, and consult a SEBI-registered advisor before making investment decisions. The Nath Bio-Genes (India) share price target outlined here is for educational purposes only.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Nath_Bio-Genes_India_Share_Price_Target_2026\"><\/span><strong>FAQs on Nath Bio-Genes (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Nath_Bio-Genes_India_share_price_target_for_2026\"><\/span><strong>What is the Nath Bio-Genes (India) share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Nath Bio-Genes (India) share price target for 2026, as per Uniresearch estimate, is Rs 225. This implies approximately 34% upside from the current market price of Rs 168.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Nath_Bio-Genes_India_a_good_stock_to_buy_right_now\"><\/span><strong>Is Nath Bio-Genes (India) a good stock to buy right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Whether Nath Bio-Genes (India) is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Nath Bio-Genes (India) share price target of Rs 225 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Nath_Bio-Genes_Indias_52-week_high_and_low\"><\/span><strong>What is Nath Bio-Genes (India)&#8217;s 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nath Bio-Genes (India)&#8217;s 52-week high is Rs 239 and the 52-week low is Rs 126, as of 29 June 2026. The current price of Rs 168 represents a 33% gain from the 52-week low.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Nath_Bio-Genes_India\"><\/span><strong>What is the market cap of Nath Bio-Genes (India)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Nath Bio-Genes (India) is approximately Rs 310 Cr, as of 29 June 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Nath_Bio-Genes_India_share_price_target\"><\/span><strong>What are the key risks to the Nath Bio-Genes (India) share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Nath Bio-Genes (India) share price target of Rs 225 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the seeds &amp; agri sector. Any of these factors could delay or reduce the target realisation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_bull_case_target_for_Nath_Bio-Genes_India_in_2026\"><\/span><strong>What is the bull case target for Nath Bio-Genes (India) in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the bull case scenario, the Nath Bio-Genes (India) share price target could reach Rs 260, implying approximately 55% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Nath_Bio-Genes_India_share_price_live\"><\/span><strong>Where can I track Nath Bio-Genes (India) share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Nath Bio-Genes (India) (NSE: NATHBIOGEN) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_I_invest_in_Nath_Bio-Genes_India_stock\"><\/span><strong>How do I invest in Nath Bio-Genes (India) stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> To invest in Nath Bio-Genes (India), open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker NATHBIOGEN on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Nath Bio-Genes (India) share price target for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Nath Bio-Genes (India) share price target for 2026, as per Uniresearch estimate, is Rs 225. This implies approximately 34% upside from the current market price of Rs 168.\"}},{\"@type\":\"Question\",\"name\":\"Is Nath Bio-Genes (India) a good stock to buy right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Whether Nath Bio-Genes (India) is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Nath Bio-Genes (India) share price target of Rs 225 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is Nath Bio-Genes (India)'s 52-week high and low?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nath Bio-Genes (India)'s 52-week high is Rs 239 and the 52-week low is Rs 126, as of 29 June 2026. The current price of Rs 168 represents a 33% gain from the 52-week low.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Nath Bio-Genes (India)?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The market capitalisation of Nath Bio-Genes (India) is approximately Rs 310 Cr, as of 29 June 2026.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks to the Nath Bio-Genes (India) share price target?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Key risks to the Nath Bio-Genes (India) share price target of Rs 225 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the seeds & agri sector. Any of these factors could delay or reduce the target realisation.\"}},{\"@type\":\"Question\",\"name\":\"What is the bull case target for Nath Bio-Genes (India) in 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In the bull case scenario, the Nath Bio-Genes (India) share price target could reach Rs 260, implying approximately 55% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.\"}},{\"@type\":\"Question\",\"name\":\"Where can I track Nath Bio-Genes (India) share price live?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can track Nath Bio-Genes (India) (NSE: NATHBIOGEN) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.\"}},{\"@type\":\"Question\",\"name\":\"How do I invest in Nath Bio-Genes (India) stock?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"To invest in Nath Bio-Genes (India), open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker NATHBIOGEN on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nath Bio-Genes (India) share price target 2026 is Rs 225 per Uniresearch estimate. CMP Rs 168, 52W High Rs 239, Low Rs 126. Bull case Rs 260, bear case Rs 180. Full analysis.<\/p>\n","protected":false},"author":35,"featured_media":138080,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-137032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782967746:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Nath Bio-Genes (India) Share Price Target 2026: Bull Case Rs 225,"],"rank_math_description":["The Nath Bio-Genes (India) share price target for 2026 is Rs 225, implying 34% upside from CMP Rs 168. 52W high Rs 239, low Rs 126. Bull case Rs 260. Expert analysis insi"],"rank_math_focus_keyword":["Nath Bio-Genes (India) share price target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["138080"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["23003"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Neuland-Laboratories-Share-Price-Target-2026-Analyst-Forecast-Bull-and-Bear-Case-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/137032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=137032"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/137032\/revisions"}],"predecessor-version":[{"id":138081,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/137032\/revisions\/138081"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/138080"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=137032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=137032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=137032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}